The IDSA/AASLD hepatitis C guidance provides healthcare professionals with timely guidance as new therapies are available and integrated into HCV regimens, IDSA and American Association for the Study of Liver Diseases (AASLD) have developed a web-based process for the rapid formulation and dissemination of evidence-based, expert-developed recommendations for hepatitis C management. The IDSA/AASLD hepatitis C guidance addresses management issues ranging from testing and linkage to care to the optimal treatment regimen in particular patient situations.
Update on the Management and Treatment of Hepatitis C Virus Infection: Recommendations from the Department of Veterans Affairs Hepatitis C Resource Center Program and the National Hepatitis C Program (PDF) (2012)Published in the American Journal of Gastroenterology, this article provides recommendations for treating and managing hepatitis C genotype 1 patients with drug therapies consisting of an oral protease inhibitor (PI), boceprevir (BOC) or telaprevir (TVR), pegaylated IFN (PegIFN), and ribavirin (RBV).
AASLD Update on Treatment of Genotype 1 Chronic Hepatitis C Virus Infection (PDF) (2011) The American Association of the Study of Liver Diseases has published an IDSA-endorsed practice guideline for the treatment of genotype 1 chronic hepatitis C patients.
AASLD Diagnosis, Management, and Treatment of Hepatitis C (PDF) (2009) Intended for use by physicians, these recommendations suggest preferred approaches to the diagnostic, therapeutic, and preventive aspects of care. They are intended to be flexible, in contrast to standards of care, which are inflexible policies to be followed in every case.
The Department of Veterans Affairs, Hepatitis C Guidelines Under the direction of the Clinical Public Health Group, the Veterans Affairs hepatitis C program provides guidelines concerning treatment, testing and counseling, HIV coinfection, clinical management, hepatocellular carcinoma, hepatitis A and B, and cirrhosis.
MedlinePlus: Hepatitis C MedlinePlus offers resources for physicians and patients: information about treatment, diagnosis and symptoms, alternative therapies, nutrition, disease management, and latest news.
National AIDS Treatment Advocacy Project, Hepatitis C NATAP offers information on drug therapies, articles, clinical drug trial progression, studies, and assistance programs related to hepatitis C and HIV.
1300 Wilson Boulevard | Suite 300 | Arlington, VA 22209 | Phone: (703) 299-0200 | Fax: (703) 299-0204
| HIVMA | Contact Us
© Copyright IDSA 2013 Infectious Diseases Society of America